Period Ending | Dec 31, 2009 | Sep 30, 2009 | Jun 30, 2009 | Mar 31, 2009 |
Total Revenue
|
4,100,166
|
3,517,630
|
3,257,352
|
3,150,762
| Cost of Revenue | 1,722,517 | 1,577,413 | 1,513,574 | 1,467,507 | |
Gross Profit
|
2,377,649
|
1,940,217
|
1,743,778
|
1,683,255
| |
|
Operating Expenses |
|
Research Development | 424,243 | 422,092 | 397,881 | 383,293 |
|
Selling General and Administrative | 1,341,873 | 1,177,775 | 1,051,204 | 1,024,773 |
|
Non Recurring | 23,903 | 34,781 | 33,234 | 15,572 |
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
587,630
|
305,569
|
261,459
|
259,617
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 16,226 | 66,128 | 31,360 | 29,086 |
|
Earnings Before Interest And Taxes | 603,856 | 371,697 | 292,819 | 288,703 |
|
Interest Expense | 46,571 | 46,227 | 44,158 | 45,543 |
|
Income Before Tax | 557,285 | 325,470 | 248,661 | 243,160 |
|
Income Tax Expense | 156,313 | 20,602 | 38,045 | 37,815 |
|
Minority Interest | (10,376) | (23,348) |
-
|
-
|
|
|
|
Net Income From Continuing Ops | 390,596 | 281,520 | 210,616 | 205,345 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
390,596
|
281,520
|
210,616
|
205,345
| Preferred Stock And Other Adjustments |
-
| 16,660 | (5,384) | (11,276) | |
Net Income Applicable To Common Shares
|
$390,596
|
$298,180
|
$205,232
|
$194,069
|
|